Back
Global DNA Synthesis Map - IBBIS
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Relevant to AI safety discussions around dual-use biotechnology risks, particularly how AI-assisted DNA design tools intersect with biosecurity screening gaps in the commercial synthesis industry.
Metadata
Importance: 52/100tool pagedataset
Summary
The International Biosecurity and Biosafety Initiative for Science (IBBIS) maintains a global map tracking DNA synthesis providers and their screening capabilities worldwide. This resource helps identify gaps in biosecurity coverage where synthesized DNA could be ordered without adequate checks for dangerous sequences. It supports efforts to establish universal screening standards across the commercial DNA synthesis industry.
Key Points
- •Maps global commercial DNA synthesis providers and their adoption of biosecurity screening protocols
- •Highlights geographic and regulatory gaps where dangerous genetic sequences could be ordered without screening
- •Supports IBBIS's mission to promote universal implementation of sequence screening in the synthesis industry
- •Relevant to biosecurity governance efforts aimed at preventing misuse of synthetic biology tools
- •Informs policymakers and researchers about the current state of industry-wide biosecurity compliance
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 20268 KB
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
[](https://ibbis.bio/)
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
Global DNA Synthesis Map
# **A global map showing how synthetic nucleic acids are produced, shipped, and regulated**
The Global DNA Synthesis Map is an [interactive online tool](https://globalsynthesismap.bio/) that shows, for the first time at a global level, where synthesis providers are located, how providers screen their orders, and what policies apply. The interactive map offers an accessible visual snapshot of data that was previously diaggregated and often hidden, highlighting regions with established biosecurity frameworks and screening requirements. The map fills information gaps about current screening practices and provides a foundation for advocacy to close biosecurity gaps.
700+ companies
provide synthetic nucleic acids, including third-party vendors and benchtop manufacturers, and **over 500 need to screen orders to guarantee compliance** with local policy
[](https://globalsynthesismap.bio/)
81 countries
identified with companies that produce or provide nucleic acids, with **local policies mapped for over 60 countries**, including export controls and pathogen licences
## Challenge: uncertainty around the global supply of synthetic DNA hampers advocacy
As DNA synthesis becomes more affordable, accessible, and globally distributed, there is an increased risk that synthetic DNA c
... (truncated, 8 KB total)Resource ID:
b81b787adf0e52e9 | Stable ID: MDZiNjZlNj